论文部分内容阅读
由于病毒性肝炎治疗上尚无特异性方法,很多学者将控制它的希望寄托于用免疫制剂进行预防。本文综述美国对病毒肝炎预防制剂的研究及使用现状。一、预防制剂与临床研究(一)免疫球蛋白:一般医疗使用的血清免疫
Due to the fact that there is no specific treatment for viral hepatitis, many scholars have pinned their hopes on the prevention with immunological agents. This article summarizes the research and application status of viral hepatitis prevention preparations in the United States. First, the prevention of agents and clinical research (A) Immunoglobulin: The general medical use of serum immunization